A Guide to NAFDAC Submissions in Nigeria for Pharma & Biotech
A Practical Guide to NAFDAC Submissions in Nigeria
Nigeria, with its large population and growing healthcare sector, is a key strategic market for many pharmaceutical and biotech companies. However, navigating the regulatory landscape, managed by the National Agency for Food and Drug Administration and Control (NAFDAC), requires deep local knowledge.
The process has its own unique set of requirements that differ significantly from the EMA or MHRA. This guide outlines the key considerations for a successful NAFDAC submission.
Key Requirements Before You Submit
Before your technical dossier is even reviewed, several foundational requirements must be in place.
- Local Representation: You must appoint a Nigerian company or individual (a “Local Agent”) to be your representative on the ground. This agent is legally responsible for the product in Nigeria.
- Company Registration: Your Local Agent must be a company registered in Nigeria with the Corporate Affairs Commission (CAC).
- Premises Registration: The Local Agent must have a registered and inspected premises (office and warehouse) suitable for handling pharmaceutical products.
- Power of Attorney: You must provide a notarized Power of Attorney (POA) to your Local Agent, granting them the authority to act on your behalf with NAFDAC.
The NAFDAC Submission Process: An Overview
While NAFDAC is moving towards the CTD format, the process remains a distinct, multi-stage operation.
Common Challenges to Avoid
- Choosing the Wrong Local Agent: Partnering with an inexperienced or uncommunicative Local Agent is the single biggest cause of delays and failures.
- Incomplete Documentation: Simple administrative errors, like improperly notarized documents or missing certificates, can lead to immediate rejection of your application.
- Dossier “Query” Management: Responding to NAFDAC’s specific questions (queries) during the review requires local insight and a rapid, clear response.